Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types (1)
Select products & services
Select solutions
Active Filters (1)
Clear All
1 - 12 of 96 Results
Sort by:
Best Match
Whitepaper
Research spotlight: new therapeutic targets focusing on aberrant lipid metabolism in Alzheimer’s disease
This whitepaper explores new therapeutic targets focusing on Aberrant Lipid Metabolism in Alzheimer's Disease
Whitepaper
Genetically engineered PDX models as patient avatars in preclinical evaluation of acute leukemias
Identifying therapeutic targets using gene silencing techniques in PDX models
Whitepaper
Guidance for ensuring your VICTOR Nivo multimode plate reader complies with 21 CFR Part 11
With specific reference to the relevant paragraphs of 21 CFR Part 11, this document describes how the tools within the VICTOR NivoTM Enhanced Security software facilitate compliance with this regulation.
Whitepaper
Get our White Paper about autoimmunity
A complete review on current and emerging therapeutic approaches for autoimmune diseases
Whitepaper
Chimeric Antigen Receptor (CAR) Natural Killer cells: a promising cell therapy strategy for cancer treatment
Featured in this white paper is information on NK cells and cytotoxicity, CAR NK cell therapy description, including genetic modification and CAR generation, and advantages, limitations, and clinical progress of CAR NK cell therapy.
Whitepaper
Download your white paper on data analysis methods
This white paper gives you tools for analyzing obtained experimental data such as 2nd messenger quantification for GPCR investigation and screening.
Whitepaper
Guidance for Ensuring Your VICTOR Nivo Multimode Plate Reader Complies with 21 CFR Part 11
With specific reference to the relevant paragraphs of 21 CFR Part 11, this document describes how the tools within the VICTOR Nivo Enhanced Security software facilitate compliance with this regulation.
Whitepaper
Meet the scientist: uncovering the pathways dictating evolution of lung cancer heterogeneity
Understanding why tumors evolve from a single cell to a heterogenous tissue could direct the development of new therapies.
Whitepaper
Murine NASH model could provide insights into NASH development and progression
Researchers explore a multidisciplinary approach to addressing current NAFLD and NASH challenges.
Whitepaper
Advancing biotherapeutic development with transposon-based technologies
Discover how to generate highly producing pools early on in your development workflow with transposon technology and accelerate time to clinic
Whitepaper
The evolving landscape of quality by design in biologics manufacturing
Implement QbD principles to meet safety, efficacy, and consistency challenges in biologics manufacturing
Whitepaper
Optimizing AAV manufacturing: a scalable harvest protocol
As demand for recombinant AAV (rAAV) vectors continues to rise, scalable and efficient manufacturing processes are essential for advancing gene therapy.
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.